4.6 Article

Overcoming Barriers to Drug Development in Children with CKD

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pediatrics

Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process

Angeliki Siapkara et al.

Summary: In order to improve the conduct of clinical trials in babies, children and young people, a working group was formed by the European Network of Paediatric Research at the European Medicines Agency. The key recommendations of the group include starting early, identifying clinical need, listening to stakeholders, estimating resources needed, and presenting information in a structured way. Well-prepared trials are likely to require fewer changes, be completed in a shorter time frame and achieve expected objectives.

ARCHIVES OF DISEASE IN CHILDHOOD (2021)

Editorial Material Medicine, General & Internal

Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation

Florence T. Bourgeois et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Pediatrics

Enhancing clinical trial development for pediatric kidney diseases

H. William Schnaper et al.

PEDIATRIC RESEARCH (2017)

Article Medical Informatics

Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United States

Dobromir Penkov et al.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2017)

Article Urology & Nephrology

Fostering Innovation, Advancing Patient Safety: The Kidney Health Initiative

Patrick Archdeacon et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Article Pediatrics

Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome

Jerome Harambat et al.

PEDIATRIC NEPHROLOGY (2013)